Important Information for Geron Corporation Shareholders Regarding Upcoming Class Action Lawsuit

Attention Geron Corporation Investors

As a shareholder of Geron Corporation (NASDAQ: GERN), you are hereby informed about an important class action securities lawsuit initiated by Levi & Korsinsky, LLP. This alert is crucial for those affected by securities fraud during the specified period of June 7, 2024, to February 25, 2025.

What’s Happening?

Levi & Korsinsky has announced a class action suit aimed at recovering losses for investors who were impacted by Geron’s alleged misinformation regarding its drug Rytelo (imetelstat). The lawsuit centers around claims that Geron exaggerated its expectations for the drug’s market performance while downplaying potential challenges, including regulatory requirements and competition.

Key Details of the Case

According to the complaint filed, the defendants allegedly provided misleading material regarding their projected growth for Rytelo, asserting that there was a significant unmet need for the drug without adequately addressing the considerable risks. The complaint highlights that on February 26, 2025, Geron revealed lackluster financial results for the fourth quarter of fiscal year 2024, indicating that Rytelo’s growth had stagnated due to various factors, such as increased competition and the burden of a weekly monitoring requirement for patients.

Following this announcement, Geron's stock plummeted drastically from $2.37 per share on February 25, 2025, down to $1.61 per share the next day—a staggering drop of over 32%. This significant decline has triggered investor concern and prompted the initiation of this class action suit.

What Should Shareholders Do?

If you were a Geron shareholder during the relevant timeframe, it is imperative to act promptly. You have until May 12, 2025 to assert your rights by requesting to be appointed as a lead plaintiff in the class action. However, don't worry if you do not wish to take that step; you can still partake in any potential recovery without being a lead plaintiff.

No Upfront Costs

Participation in this lawsuit is at no cost to you. If you're recognized as a class member, you may receive compensation without any out-of-pocket expenses. This means you can explore your rights with no financial obligations nor risks involved.

Why Choose Levi & Korsinsky?

Levi & Korsinsky comes with an impressive track record, having secured hundreds of millions of dollars for affected shareholders over the past two decades. With a dedicated team of over 70 professionals experienced in complex securities litigation, they have earned a reputation as one of the top firms in the sector. The firm has been recognized consistently by leading industry rankings, which can give you confidence in their ability to represent your interests effectively.

Contact Information

If you are a Geron Corporation investor and have experienced losses during the specified period, you can reach out directly to Joseph E. Levi, Esq., via email at [email protected] or by phone at (212) 363-7500. This is your opportunity to take action and ensure your voice is heard in the ongoing legal proceedings.

Stay informed and proactive regarding your rights as a shareholder as this lawsuit unfolds. Protect your investments and consider connecting with Levi & Korsinsky before the important deadline of May 12, 2025.